Sandoz Shuffles Management And Sets Out Restructuring Plans

As ‘Fantastic Progress’ On Biosimilars Drives Sales Growth Of Almost A Tenth In Q2

 
• By David Wallace
  
Company structure, management layers
Sandoz is reducing layers and simplifying its organization • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Leadership

More from Generics Bulletin